The historical rank and industry rank for Bio-Techne's 3-Year Dividend Growth Rate or its related term are showing as below:
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bio-Techne was 13.90% per year. The lowest was 0.20% per year. And the median was 4.60% per year.
BSP:T1CH34's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 13.55 * Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
During the past 10 years, the average Dividends Per Share Growth Rate was 0.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Bio-Techne's 3-Year Dividend Growth Rate
For the Biotechnology subindustry, Bio-Techne's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Bio-Techne's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Bio-Techne was 0.51. The lowest was 0.16. And the median was 0.31.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Bio-Techne Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
BRL 0.009
2024-02-08
2024-02-07
2024-03-01
Cash Dividend
quarterly
BRL:BRL 1.000000
BRL 0.009
2023-11-09
2023-11-08
2023-11-30
Cash Dividend
quarterly
BRL:BRL 1.000000
BRL 0.013
2023-08-17
2023-08-16
2023-09-08
Cash Dividend
quarterly
BRL:BRL 1.000000
BRL 0.013
2023-05-12
2023-05-11
2023-06-01
Cash Dividend
quarterly
BRL:BRL 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Bio-Techne's Dividend Yield (%) for Today is calculated as
Current Share Price is R$10.95.
Bio-Techne's Dividends per Share for the trailing twelve months (TTM) ended in Today is R$0.044.
During the past 13 years, the highest Dividend Yield of Bio-Techne was 1.79%. The lowest was 0.24%. And the median was 0.76%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne 3-Year Dividend Growth Rate Related Terms>
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:T1CH34 has been successfully added to your